LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.840
-0.050 (-2.65%)
Nov 7, 2024, 4:00 PM EST - Market closed
LAVA Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for LAVA Therapeutics stock have an average target of 6.00, which predicts an increase of 226.09% from the current stock price of 1.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
The average analyst rating for LVTX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +226.09% | Aug 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +226.09% | Jun 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +226.09% | Mar 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +226.09% | Nov 17, 2023 |
JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +226.09% | Aug 23, 2023 |
Financial Forecast
Revenue This Year
3.57M
from 6.77M
Decreased by -47.32%
Revenue Next Year
n/a
from 3.57M
EPS This Year
-1.17
from -1.57
EPS Next Year
-1.98
from -1.17
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.3M | n/a | n/a | ||
Avg | 3.6M | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 8.5% | - | - | ||
Avg | -47.3% | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.14 | -1.70 | -1.61 | ||
Avg | -1.17 | -1.98 | -1.92 | ||
Low | -1.18 | -2.21 | -2.20 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.